|
2026 Book Chapter The breastSokolova, Anna, Simpson, Peter T. and Lakhani, Sunil R. (2026). The breast. Robbins, Cotran & Kumar pathologic basis of disease. (pp. 944-969) edited by Jon C. Aster, Abul K. Abbas, Vinay Kumar, Jayanta Debnath and Abhijit Das. Philadelphia, PA United States: Elsevier. |
|
2025 Conference Publication Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breastWong, Clarissa Jing Wen, Nasir, Nur Diyana Md, Koh, Valerie Cui Yun, Campbell, Fiona, Fox, Stephen, Lakhani, Sunil R., Myles, Nickolas, Yip, George, Colling, Richard, Cree, Ian A., Lokuhetty, Dilani and Tan, Puay Hoon (2025). Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breast. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.FCS2024-P78 |
|
2025 Journal Article Genomic predictive biomarkers in breast cancer: the haves and have notsBeecher, Kate, Kulasegaran, Tivya, Lakhani, Sunil R. and McCart Reed, Amy E. (2025). Genomic predictive biomarkers in breast cancer: the haves and have nots. International Journal of Molecular Sciences, 26 (15) 7300, 7300-15. doi: 10.3390/ijms26157300 |
|
2025 Conference Publication Multi-omic explainable machine learning improves cancer treatment outcome predictionTran, Khoa A., Addala, Venkateswar, Koufariotis, Lambros T., Zhang, Jia, Wood, Scott, Leonard, Conrad, Hoeijmakers, Lotte L., Blank, Christian U., Crispin-Ortuzar, Mireia, McCart. Reed, Amy, Inglis, Po-ling, Lakhani, Sunil R., Williams, Elizabeth D., Pearson, John V., Kondrashova, Olga and Waddell, Nicola (2025). Multi-omic explainable machine learning improves cancer treatment outcome prediction. AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning, Montreal, QC Canada, 10-12 July 2025. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1557-3265.aimachine-a051 |
|
2025 Conference Publication OlympiA: A phase 3, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients w/ germline BRCA1 & BRCA2 pathogenic variants & highrisk HER2-negative primary breast cancerGarber, Judy, Cameron, David, Campbell, Christine, Yothers, Greg, Taboada, Maria, El-Abed, Sarra, Rastogi, Priya, Paterson, Vicki, Kang, Jinyu, Zafonte, Stephanie, Liu, Xiaochun, Viale, Giuseppe, Spanic, Tanja, Schmutzler, Rita, Piccart, Martine, Loibl, Sibylle, Linderholm, Barbro, Lakhani, Sunil R., Korde, Larissa, Gnant, Michael, Gelmon, Karen, Friedman, Sue, Freeman, Tanner, Domchek, Susan M., Aktan, Gursel, Gelber, Richard D., Geyer, Charles E. and Tutt, Andrew N. J. (2025). OlympiA: A phase 3, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients w/ germline BRCA1 & BRCA2 pathogenic variants & highrisk HER2-negative primary breast cancer. San Antonio Breast Cancer Symposium, San Antonio Tx, Dec 10-13, 2024. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1557-3265.SABCS24-GS1-09 |
|
2025 Conference Publication Early detection of ovarian cancer: An accurate high-throughput extracellular vesicle testSalomon, Carlos, Lai, Andrew, Guanzon, Dominic, Sharma, Shayna, Scholz-Romero, Katherin, Razo, Melissa, Barnard, Amanda, Choolani, Mahesh, Palma, Carlos, Khanabdali, Ramin, Lakhani, Sunil R., Coward, Jermaine, Hinch, Leearne, Ferguson, Kaltin, Perrin, Lewis, Lourie, Rohan, DeFazio, Anna, Hooper, John D. and Rice, Gregory Edward (2025). Early detection of ovarian cancer: An accurate high-throughput extracellular vesicle test. 2025 ASCO Annual Meeting, Chicago, IL United States, 30 May - 3 June 2025. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2025.43.16_suppl.5582 |
|
2025 Journal Article ROS1 immunohistochemistry as a potential predictive biomarker for ROS1-targeted therapy in breast cancer: impact of antibody clone selectionSokolova, Anna, Joshi, Vaibhavi, Chittoory, Haarika, Walsh, Michael, Lim, Malcolm, Kutasovic, Jamie R., Ferguson, Kaltin, Simpson, Peter T., Lakhani, Sunil R. and Reed, Amy E. McCart (2025). ROS1 immunohistochemistry as a potential predictive biomarker for ROS1-targeted therapy in breast cancer: impact of antibody clone selection. Histopathology, 87 (2), 223-234. doi: 10.1111/his.15465 |
|
2025 Journal Article Classification of fibroepithelial lesions of the breast in core needle biopsy with implications for further managementRakha, Emad A., Quinn, Cecily, Raymond, Wendy, Allison, Kimberly H., Badve, Sunil S., Brogi, Edi, Callagy, Grace, Charafe-Jauffret, Emmanuelle, Chen, Chih Jung, Chen, Yunn-Yi, Collins, Laura C., Cserni, Gábor, Djerroudi, Lounes, Jaffer, Shabnam, Foschini, Maria Pia, Gobbi, Helenice, Gudi, Mihir, Harada, Oi, Kulka, Janina, Kuroda, Hajime, Lakhani, Sunil R., Li, Xiaoxian, Moriya, Takuya, O'Toole, Sandra A., Pinder, Sarah E., Provenzano, Elena, Sahin, Aysegul A., Schmitt, Fernando, Shaaban, Abeer M. ... Tan, Puay Hoon (2025). Classification of fibroepithelial lesions of the breast in core needle biopsy with implications for further management. Modern Pathology, 38 (5) 100734, 1-21. doi: 10.1016/j.modpat.2025.100734 |
|
2025 Journal Article Malignant phyllodes tumours of the breast: the case for revising <scp>WHO’</scp>s ‘full house’ diagnostic criteriaTan, Puay Hoon, Ellis, Ian O, Allison, Kimberly H, Badve, Sunil S, Brogi, Edi, Callagy, Grace, Charafe‐Jauffret, Emmanuelle, Chen, Chih‐Jung, Chen, Yunn‐Yi, Collins, Laura C, Cserni, Gábor, Djerroudi, Lounes, Foschini, Maria Pia, Fox, Stephen B, Gobbi, Helenice, Gudi, Mihir, Harada, Oi, Jaffer, Shabnam, Kulka, Janina, Kuroda, Hajime, Lakhani, Sunil R, Li, Xiaoxian, Moriya, Takuya, O'Toole, Sandra, Pinder, Sarah E, Provenzano, Elena, Quinn, Cecily, Raymond, Wendy, Sahin, Aysegul A ... Rakha, Emad A (2025). Malignant phyllodes tumours of the breast: the case for revising WHO’s ‘full house’ diagnostic criteria. Histopathology, 87 (2), 169-182. doi: 10.1111/his.15455 |
|
2025 Journal Article A short ERK5 isoform modulates nucleocytoplasmic shuttling of active ERK5 and associates with poor survival in breast cancerMiranda, Mariska, Saunus, Jodi M., Akgül, Seçkin, Marjaneh, Mahdi Moradi, Kutasovic, Jamie R., Shi, Wei, Chatterjee, Oishee, Casciello, Francesco, Rozali, Esdy, Handoko, Herlina Y., Wiegmans, Adrian P., Liu, Tianqing, Lee, Jason S., Day, Bryan W., Edwards, Stacey L., French, Juliet D., McCart Reed, Amy E., Chenevix-Trench, Georgia, Khanna, Kum Kum, Simpson, Peter T., Lakhani, Sunil R. and Al-Ejeh, Fares (2025). A short ERK5 isoform modulates nucleocytoplasmic shuttling of active ERK5 and associates with poor survival in breast cancer. Fortune Journal of Health Sciences, 250-266. doi: 10.26502/fjhs.271 |
|
2025 Journal Article Improved breast cancer diagnosis using a CA15-3 capture antibody-lectin sandwich assayNikseresht, S., Shewell, L. K., Day, C. J., Jennings, M. P., Chittoory, H., McCart Reed, A. E., Simpson, P. T., Lakhani, S. R., Nabiee, R., Moore, M., Khanabdali, R., Hinch, L. M. and Rice, G. E. (2025). Improved breast cancer diagnosis using a CA15-3 capture antibody-lectin sandwich assay. Breast Cancer Research and Treatment, 211 (3) 188534, 1-11. doi: 10.1007/s10549-025-07672-z |
|
2025 Journal Article Extracellular vesicle miRNAs from three-dimensional ovarian cancer in vitro models and their implication in overall cancer survivalGodbole, Nihar, Lai, Andrew, Carrion, Flavio, Scholz-Romero, Katherin, Ravichandran, Akhilandeshwari, Kalita-de Croft, Priyakshi, McCart Reed, Amy E., Joshi, Vaibhavi, Lakhani, Sunil R., Masud, Mostafa Kamal, Yamauchi, Yusuke, Perrin, Lewis, Hooper, John, Bray, Laura, Guanzon, Dominic and Salomon, Carlos (2025). Extracellular vesicle miRNAs from three-dimensional ovarian cancer in vitro models and their implication in overall cancer survival. Heliyon, 11 (4) e42188, 1-19. doi: 10.1016/j.heliyon.2025.e42188 |
|
2025 Conference Publication A rare case of focally invasive cystic hypersecretory carcinoma associated with pregnancy-like hyperplasia and invasive carcinoma NSTPelser, T., Martin, D. and Lakhani, S. (2025). A rare case of focally invasive cystic hypersecretory carcinoma associated with pregnancy-like hyperplasia and invasive carcinoma NST. Pathology Update 2025, Melbourne, VIC Australia, 21-23 February 2025. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2024.12.262 |
|
2025 Journal Article Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypesPareja, Fresia, Bhargava, Rohit, Borges, Virginia F., Brogi, Edi, Canas Marques, Rita, Cardoso, Fatima, Desmedt, Christine, Harigopal, Malini, Lakhani, Sunil R., Lee, Adrian, Leone, Jose Pablo, Linden, Hannah, Lord, Christopher J., Marchio, Caterina, Merajver, Sofia D., Rakha, Emad, Reis-Filho, Jorge S., Richardson, Andrea, Sawyer, Elinor, Schedin, Pepper, Schwartz, Christopher J., Tutt, Andrew, Ueno, Naoto T., Vincent-Salomon, Anne, Weigelt, Britta, Wen, Y. Hannah, Schnitt, Stuart J. and Oesterreich, Steffi (2025). Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes. Npj Breast Cancer, 11 (1) 6, 1-13. doi: 10.1038/s41523-025-00719-w |
|
2025 Journal Article Clinically boosting cancer molecular targeted radioligand therapies with innovative nanomaterialsLim, Malcom, Simpson, Peter T., Lakhani, Sunil R., Masud, Mostafa, Puttick, Simon, Rose, Stephen, Roberts, Matthew J. and Koo, Kevin M. (2025). Clinically boosting cancer molecular targeted radioligand therapies with innovative nanomaterials. ChemNanoMat, 11 (1) e202400449. doi: 10.1002/cnma.202400449 |
|
2024 Journal Article Pregnancy-related factors and breast cancer risk for women across a range of familial riskMcDonald, Jasmine A., Liao, Yuyan, Knight, Julia A., John, Esther M., Kurian, Allison W., Daly, Mary, Buys, Saundra S., Huang, Yun, Frost, Caren J., Andrulis, Irene L., Colonna, Sarah V., Friedlander, Michael L., Hopper, John L., Chung, Wendy K., Genkinger, Jeanine M., MacInnis, Robert J., Terry, Mary Beth, Kathleen Cuningham Foundation Consortium investigators, Amor, David, Andrews, Lesley, Antill, Yoland, Balleine, Rosemary, Beesley, Jonathan, Bennett, Ian, Bogwitz, Michael, Bodek, Simon, Botes, Leon, Brennan, Meagan, Brown, Melissa ... Zaheed, Milita (2024). Pregnancy-related factors and breast cancer risk for women across a range of familial risk. JAMA Network Open, 7 (8) e2427441, 1-17. doi: 10.1001/jamanetworkopen.2024.27441 |
|
2024 Journal Article A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR)Bossuyt, Veerle, Provenzano, Elena, Symmans, W Fraser, Webster, Fleur, Allison, Kimberly H., Dang, Chau, Helenice, Gobbi, Kulka, Janina, Lakhani, Sunil R., Moriya, Takuya, Quinn, Cecily M., Sapino, Anna, Schnitt, Stuart, Sibbering, D. Mark, Slodkowska, Elzbieta, Yang, Wentao, Tan, Puay Hoon and Ellis, Ian (2024). A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 84 (7), 1111-1129. doi: 10.1111/his.15165 |
|
2024 Conference Publication LobSig4 is a superior and readily implementable ILC-focussed prognostic biomarker setKalinowski, Lauren, Kutasovic, Jamie, Srihari, Sriganesh, Feng, Yufan, Lal, Samir, Ferguson, Kaltin, Chittoory, Haarika, Sokolova, Anna, Lim, Malcolm, De Croft, Priyakshi Kalita, Lakhani, Sunil, Simpson, Peter and Reed, Amy McCart (2024). LobSig4 is a superior and readily implementable ILC-focussed prognostic biomarker set. San Antonio Breast Cancer Symposium 2023, San Antonio, TX United States, 5-9 December 2023. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.sabcs23-po3-15-09 |
|
2024 Journal Article B7-H3 expression in breast cancer and brain metastasisJoshi, Vaibhavi, Beecher, Kate, Lim, Malcolm, Stacey, Andrew, Feng, Yufan, Jat, Parmjit S., Duijf, Pascal H. G., Simpson, Peter T., Lakhani, Sunil R. and McCart Reed, Amy E. (2024). B7-H3 expression in breast cancer and brain metastasis. International Journal of Molecular Sciences, 25 (7) 3976, 1-17. doi: 10.3390/ijms25073976 |
|
2024 Conference Publication Evaluating the accuracy of 18F-FDG PET-MRI scan in detecting regional lymph node disease in high risk breast cancer patients: PETAL studyMurugappan, K., Lakhani, S., Ung, O., Kenny, L., Thomas, P., Rezai, S., Niland, C., McMahon, K. and Tran, S. (2024). Evaluating the accuracy of 18F-FDG PET-MRI scan in detecting regional lymph node disease in high risk breast cancer patients: PETAL study. Australasian Society for Breast Disease 13th Scientific Meeting, Adelaide, SA, Australia, 14-16 September 2023. London, United Kingdom: Churchill Livingstone. doi: 10.1016/j.breast.2023.103631 |
